| Dr Yueyang Guo, MD | |
|
200 W Arbor Dr, San Diego, CA 92103-9000 | |
| (800) 926-8273 | |
| (888) 539-8781 |
| Full Name | Dr Yueyang Guo |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 11 Years |
| Location | 200 W Arbor Dr, San Diego, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033542006 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | A132313 (California) | Secondary |
| 2085N0700X | Radiology - Neuroradiology | A132313 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uc San Diego Health Hillcrest - Hillcrest Med Ctr | San diego, CA | Hospital |
| Grossmont Hospital | La mesa, CA | Hospital |
| Palomar Health Downtown Campus | Escondido, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California | 3577476761 | 1692 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Depression is on the rise in the United States, according to researchers at Columbia University's Mailman School of Public Health and the CUNY Graduate School of Public Health and Health Policy. From 2005 to 2015, depression rose significantly among Americans age 12 and older with the most rapid increases seen in young people. The findings appear online in the journal Psychological Medicine.
The Foundation for Innovative New Diagnostics (FIND) announced today the launch of a request for proposals (RFP) to accelerate the development, manufacturing, and market availability of accurate, affordable, quality-assured and easy-to-use SARS-CoV-2 self-tests for use in low- and middle-income countries (LMICs).
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
The University of South Florida School of Physical Therapy & Rehabilitation Sciences has received a $1.59-million U.S. Department of Defense award for leading-edge musculoskeletal research intended to benefit active duty soldiers and veterans and improve military preparedness.
› Verified 9 days ago
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Depression is on the rise in the United States, according to researchers at Columbia University's Mailman School of Public Health and the CUNY Graduate School of Public Health and Health Policy. From 2005 to 2015, depression rose significantly among Americans age 12 and older with the most rapid increases seen in young people. The findings appear online in the journal Psychological Medicine.
The Foundation for Innovative New Diagnostics (FIND) announced today the launch of a request for proposals (RFP) to accelerate the development, manufacturing, and market availability of accurate, affordable, quality-assured and easy-to-use SARS-CoV-2 self-tests for use in low- and middle-income countries (LMICs).
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
The University of South Florida School of Physical Therapy & Rehabilitation Sciences has received a $1.59-million U.S. Department of Defense award for leading-edge musculoskeletal research intended to benefit active duty soldiers and veterans and improve military preparedness.
› Verified 9 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558463927 PECOS PAC ID: 3577476761 Enrollment ID: O20040107000584 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Depression is on the rise in the United States, according to researchers at Columbia University's Mailman School of Public Health and the CUNY Graduate School of Public Health and Health Policy. From 2005 to 2015, depression rose significantly among Americans age 12 and older with the most rapid increases seen in young people. The findings appear online in the journal Psychological Medicine.
The Foundation for Innovative New Diagnostics (FIND) announced today the launch of a request for proposals (RFP) to accelerate the development, manufacturing, and market availability of accurate, affordable, quality-assured and easy-to-use SARS-CoV-2 self-tests for use in low- and middle-income countries (LMICs).
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
The University of South Florida School of Physical Therapy & Rehabilitation Sciences has received a $1.59-million U.S. Department of Defense award for leading-edge musculoskeletal research intended to benefit active duty soldiers and veterans and improve military preparedness.
› Verified 9 days ago
| Entity Name | X-ray Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740232776 PECOS PAC ID: 5294796801 Enrollment ID: O20041026000600 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Depression is on the rise in the United States, according to researchers at Columbia University's Mailman School of Public Health and the CUNY Graduate School of Public Health and Health Policy. From 2005 to 2015, depression rose significantly among Americans age 12 and older with the most rapid increases seen in young people. The findings appear online in the journal Psychological Medicine.
The Foundation for Innovative New Diagnostics (FIND) announced today the launch of a request for proposals (RFP) to accelerate the development, manufacturing, and market availability of accurate, affordable, quality-assured and easy-to-use SARS-CoV-2 self-tests for use in low- and middle-income countries (LMICs).
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
The University of South Florida School of Physical Therapy & Rehabilitation Sciences has received a $1.59-million U.S. Department of Defense award for leading-edge musculoskeletal research intended to benefit active duty soldiers and veterans and improve military preparedness.
› Verified 9 days ago
| Entity Name | Lpch Medical Group Div Of Lucile |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907940 PECOS PAC ID: 0840298543 Enrollment ID: O20061113000232 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Depression is on the rise in the United States, according to researchers at Columbia University's Mailman School of Public Health and the CUNY Graduate School of Public Health and Health Policy. From 2005 to 2015, depression rose significantly among Americans age 12 and older with the most rapid increases seen in young people. The findings appear online in the journal Psychological Medicine.
The Foundation for Innovative New Diagnostics (FIND) announced today the launch of a request for proposals (RFP) to accelerate the development, manufacturing, and market availability of accurate, affordable, quality-assured and easy-to-use SARS-CoV-2 self-tests for use in low- and middle-income countries (LMICs).
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
The University of South Florida School of Physical Therapy & Rehabilitation Sciences has received a $1.59-million U.S. Department of Defense award for leading-edge musculoskeletal research intended to benefit active duty soldiers and veterans and improve military preparedness.
› Verified 9 days ago
| Entity Name | Regents Of The University Of California Ucsd Department Of Radiology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225213655 PECOS PAC ID: 8224108741 Enrollment ID: O20080610000132 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Depression is on the rise in the United States, according to researchers at Columbia University's Mailman School of Public Health and the CUNY Graduate School of Public Health and Health Policy. From 2005 to 2015, depression rose significantly among Americans age 12 and older with the most rapid increases seen in young people. The findings appear online in the journal Psychological Medicine.
The Foundation for Innovative New Diagnostics (FIND) announced today the launch of a request for proposals (RFP) to accelerate the development, manufacturing, and market availability of accurate, affordable, quality-assured and easy-to-use SARS-CoV-2 self-tests for use in low- and middle-income countries (LMICs).
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
The University of South Florida School of Physical Therapy & Rehabilitation Sciences has received a $1.59-million U.S. Department of Defense award for leading-edge musculoskeletal research intended to benefit active duty soldiers and veterans and improve military preparedness.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yueyang Guo, MD Po Box 232410, San Diego, CA 92193-2410 Ph: () - | Dr Yueyang Guo, MD 200 W Arbor Dr, San Diego, CA 92103-9000 Ph: (800) 926-8273 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Depression is on the rise in the United States, according to researchers at Columbia University's Mailman School of Public Health and the CUNY Graduate School of Public Health and Health Policy. From 2005 to 2015, depression rose significantly among Americans age 12 and older with the most rapid increases seen in young people. The findings appear online in the journal Psychological Medicine.
The Foundation for Innovative New Diagnostics (FIND) announced today the launch of a request for proposals (RFP) to accelerate the development, manufacturing, and market availability of accurate, affordable, quality-assured and easy-to-use SARS-CoV-2 self-tests for use in low- and middle-income countries (LMICs).
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
The University of South Florida School of Physical Therapy & Rehabilitation Sciences has received a $1.59-million U.S. Department of Defense award for leading-edge musculoskeletal research intended to benefit active duty soldiers and veterans and improve military preparedness.
› Verified 9 days ago
Dr. Lejla Aganovic, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 Fax: 888-539-8781 | |
Dr. Zachary G. Rattner, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 995 Gateway Center Way, Suite 207, San Diego, CA 92102 Phone: 619-263-9729 Fax: 619-263-9730 | |
Dr. Soheil Niku, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 12580 Carmel Creek Rd, #52, San Diego, CA 92130 Phone: 619-322-0341 Fax: 858-509-0341 | |
Dr. Frank B. Hamlett, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 319 Laurel St, San Diego, CA 92101 Phone: 619-234-3918 Fax: 619-234-5342 | |
Dr. Aaron Mathew Smith, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 7910 Frost St, San Diego, CA 92123 Phone: 858-939-3600 | |
Dr. Paul S Schulman, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 4352 Trias St, San Diego, CA 92103 Phone: 619-997-8881 Fax: 619-795-9980 | |
Dr. Alan L Lurie, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 501 Washington St, Ste 510, San Diego, CA 92103 Phone: 619-819-6501 |